Topical lidocaine helps reduce pain of digital ulcers in systemic sclerosis (scleroderma)

Clinical Rheumatology

Volumn 25, Issue 3, 2006, Pages 378-379

  Ozgocmen, Salih ^a   Kaya, Arzu ^a   Coskun, Basak Kandi ^a  

^a FIRAT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CIPROFLOXACIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUSIDATE SODIUM; GLUCOCORTICOID; LIDOCAINE; PENICILLAMINE; PENTOXIFYLLINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANALGESIA; APPLICATION SITE PAIN; ARTICLE; CASE REPORT; CELLULITIS; DEPRESSION; FEMALE; FINGER; HUMAN; HYPERTENSION; NOCICEPTION; OSTEOPOROSIS; PATIENT SATISFACTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RAYNAUD PHENOMENON; SKIN ULCER; SYSTEMIC SCLEROSIS; TOE;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANESTHETICS, LOCAL; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG THERAPY, COMBINATION; FEMALE; FUSIDIC ACID; HUMANS; LIDOCAINE; MIDDLE AGED; PAIN; SCLERODERMA, SYSTEMIC; SKIN ULCER; TREATMENT OUTCOME;

EID: 33645764673     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-0016-1     Document Type: Article

References (4)

1. Wigley FM, Hummers LK (2003) Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weismann WH (eds) Rheumatology. Mosby, Philadelphia, pp 1463-1480
2. Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E et al (2004) Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50:3985-3993
3. Yoon J, Giacopelli J, Granoff D, Kobayashi W (2002) Treatment of scleroderma skin ulcers using becaplermin gel and hydrocolloid membrane. J Am Podiatr Med Assoc 92:350-354
4. Denton CP, Korn JH (2003) Digital ulceration and critical digital ischemia in scleroderma. Scleroderma Care Res 1:12-16